Transfusional hemosiderosis in childhood cancer patients and survivors
- 3 August 2024
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (10) , e31220
Abstract
Background: Children treated for cancer are at risk for adverse effects of iron due to transfusions administered during prolonged marrow suppression, which may increase exposure to toxic forms of iron, extrahepatic iron accumulation, and long‐term organ damage.Objective: This study aimed to characterize the severity and organ distribution of clinically significant, multisystem iron overload (IO) in an at‐risk cohort of pediatric cancer patients.Methods: This was a retrospective, cross‐sectional study of childhood cancer patients who underwent a magnetic resonance imaging (MRI) due to clinical concern for IO. Data regarding cancer type and treatment, transfusion history, MRI and laboratory results, and treatment for IO were collected. Severity of IO was analyzed by non‐parametric tests with respect to clinical characteristics.Results: Of the 103 patients, 98% of whom had a Cancer Intensity Treatment Rating (ITR‐3) of 3 or higher, 53% (54/102) had moderate or greater hepatic siderosis, 80% (77/96) had pancreatic siderosis, 4% (3/80) had cardiac siderosis, and 45% (13/29) had pituitary siderosis and/or volume loss. Pancreatic iron was associated with both cardiac (p = .0043) and pituitary iron (p = .0101). In the 73 off‐therapy patients, ferritin levels were lower (p = .0008) with higher correlation with liver iron concentration (LIC) (p = .0016) than on‐therapy patients. Fifty‐eight subjects were treated for IO.Conclusion: In this heavily treated cohort of pediatric cancer patients, more than 80% had extrahepatic iron loading, which occurs with significant exposure to toxic forms of iron related to decreased marrow activity in setting of transfusions. Further studies should examine the effects of exposure to reactive iron on long‐term outcomes and potential strategies for management.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administrationAmerican Journal of Hematology, 2023
- Ferritin trends do not predict changes in total body iron in patients with transfusional iron overloadAmerican Journal of Hematology, 2014
- Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young ageAmerican Journal of Hematology, 2013
- Iron overload in children undergoing cancer treatmentsPediatric Blood & Cancer, 2013
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerJAMA, 2013
- Association of projected transfusional iron burden with treatment intensity in childhood cancer survivorsPediatric Blood & Cancer, 2011
- Pituitary iron and volume predict hypogonadism in transfusional iron overloadAmerican Journal of Hematology, 2011
- Pancreatic iron and glucose dysregulation in thalassemia majorAmerican Journal of Hematology, 2011
- A revision of the intensity of treatment rating scale: Classifying the intensity of pediatric cancer treatmentPediatric Blood & Cancer, 2011
- Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complicationsBlood Cells, Molecules, and Diseases, 2011